Target intelligence / Profile preview

Endogenous chromatin and transcriptional cofactor complexes in cardiac cells

Molecular classification
Transcription factor, Histone modification, Chromatin remodeling complex, Coactivator, Corepressor
01

Overview

Endogenous chromatin and transcriptional cofactor complexes in cardiac cells represent a broad category of multi-protein assemblies that regulate the epigenetic landscape and gene expression profiles essential for heart development and function. These complexes, such as the SWI/SNF (BAF) remodeling complex, the Mediator complex, and various histone acetyltransferases (e.g., p300/CBP), interact with lineage-specific transcription factors like GATA4 and MEF2 to orchestrate cardiac-specific gene programs. In pathological states such as heart failure or hypertrophy, these complexes undergo remodeling or post-translational modifications that drive maladaptive gene expression. While specific components like BRD4 or HDACs are targeted by small molecules (e.g., BET inhibitors or HDAC inhibitors) to treat cardiovascular diseases, the term itself refers to a heterogeneous group of biological machinery rather than a single therapeutic target. Understanding the precise composition of these endogenous complexes is a major focus of cardiac proteomic and genomic research to identify more specific points of intervention.

Other names
Cardiac transcriptional regulatory complexesCardiac chromatin remodeling complexesCardiac epiproteome
02

Mechanism of action

Inhibition of bromodomain and extra-terminal (BET) proteins to prevent recruitment of transcriptional cofactors; inhibition of histone deacetylases (HDACs) to alter chromatin accessibility.

03

Biological functions

Transcription regulationChromatin remodelingEpigenetic regulationCell differentiationCardiac developmentStress response
04

Disease associations

Cardiovascular diseaseHeart failureCardiac hypertrophyCongenital heart defectArrhythmia
05

Safety considerations

Off-target transcriptional effectsSystemic toxicity due to ubiquitous expression of cofactor complexesPotential for developmental defectsCardiotoxicity from unintended epigenetic silencing
06

Interacting drugs

Apabetalone

3 more in the full profile.

07

Biomarkers

H3K27acH3K4me3GATA4NKX2-5TBX5

Beyond the preview

Go deeper on Endogenous chromatin and transcriptional cofactor complexes in cardiac cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endogenous chromatin and transcriptional cofactor complexes in cardiac cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call